Immunotherapy Industry, December 2014 Market Reports from Top Publishers

You might be interested in: Therapeutics, Cancer, Medical Equipment, more »


 
1-10 of 49 reports for Immunotherapy

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Amplification helps development of personalized active immunotherapies. Genitope help patients who are diagnosed with b-cell malignancies. The company is headquartered in california, the us ...

Biotec Pharmacon ASA (Symbol:BIOTEC) SWOT Analysis, Strategy, Revenues and Profits

Biotec Pharmacon ASA (Symbol:BIOTEC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Including immunotherapy of cancer, general infection prophylaxis, and imbalanced immune responses. Biotec pharmacon is headquartered in tromso, norway.Biotec pharmacon asa key recent developments ...

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Which is a personalized t-cell immunotherapy in a phase iib clinical development program for the treatment of secondary progressive multiple sclerosis. The company specializes in flow cytometry ...

Compugen Ltd. (Symbol:CGEN) SWOT Analysis, Strategy, Revenues and Profits

Compugen Ltd. (Symbol:CGEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Compugen ltd. Key recent developmentsoct 29, 2014: compugen reports third quarter 2014 financial resultsoct 14, 2014: compugen achieves second preclinical milestone in cancer immunotherapy ...

Sorrento Therapeutics, Inc. (Symbol:SRNE) SWOT Analysis, Strategy, Revenues and Profits

Sorrento Therapeutics, Inc. (Symbol:SRNE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Is headquartered in san diego, california, the us.Sorrento therapeutics, inc. Key recent developmentsaug 26, 2014: sorrento awarded nih grant to advance immunotherapy targeting idiopathic pulmonary ...

Oncothyreon Inc. (ONTY) - Financial and Strategic SWOT Analysis Review

Oncothyreon Inc. (ONTY) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Ont-10 and tecemotide constitute to oncothyreon s antigen- specific immunotherapy platform. It also focuses on clinical development and market commercialization of its pipeline programs. The company ...

Dendritic Cell and CAR-T Therapies Market, 2014 - 2024

Dendritic Cell and CAR-T Therapies Market, 2014 - 2024

  • $ 1 899
  • Industry report
  • November 2014
  • by Roots Analysis Private Ltd.

... Firms developing whole cell based immunotherapies. - Competitive landscape and inherent threats to growth in the short and long term. - Development and sales potential based on target consumer ...

Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... And commercialize adjuvanted vaccine and immunotherapy technology in the field of human health. It has strategic alliance with bayer healthcare ag for the use of its technology in the field of animal health. Juvaris ...

ImmunoCellular Therapeutics, Ltd. (IMUC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ImmunoCellular Therapeutics, Ltd. (IMUC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... S immunotherapies product pipeline comprises lead prduct cand, ict-107, ict-140, ict-121. Ict-107 is being developed for the treatment of glioblastoma multiforme (gbm); ict-140, a dc vaccine designed to treat ...

Immunomic Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immunomic Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... Vaccines to treat disease applications in human and animal health. Its vaccines include ara-lamp-vax, multi-lamp-vax, jrc-lamp-vax, hiv-lamp-vax, and grnvac1/2 cancer immunotherapy. The company develops ...

About 700 reports for Immunotherapy

Download Unlimited Documents from Trusted Public Sources

Medinet Annual Report 2013

  • January 2013
    171 pages
  • Equity Market  

    Preferred Stock  

    Common Stock  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.